Dr. Jesse Roth, a leading endocrinologist whose research fundamentally changed the understanding of diabetes, passed away on March 11th at his home in New York. He was 91 years old. His work demonstrated that diabetes doesn’t just stem from insufficient insulin, but from cells’ inability to properly respond to it – a breakthrough rooted in the discovery of faulty insulin receptors.
A Career Dedicated to Hormonal Understanding
For over 50 years, Dr. Roth dedicated his career to unraveling the complexities of hormones and their interactions with cells. He spent nearly three decades at the National Institutes of Health (NIH) in Bethesda, Maryland, where he didn’t just conduct research; he shaped the next generation of scientists.
His tenure at the NIH began in 1963, during a period when the biological mechanisms behind insulin resistance were still largely unknown. Dr. Roth’s team was among the first to prove that cells possess specialized protein receptors that bind to insulin, and that defects in these receptors can lead to diabetes. This wasn’t simply an academic question; it explained why some people with normal insulin levels still developed the disease.
From NIH to Johns Hopkins and Beyond
In 1991, Dr. Roth moved to Johns Hopkins University, continuing his research into hormonal regulation. He then joined the Feinstein Institutes for Medical Research in Manhasset, New York, in 2000. Even into his 80s, he remained an active researcher, expanding his work to include obesity and other hormone-related conditions.
“He was energized by science, and his enthusiasm was infectious,” said Dr. Betty Diamond, director of the Institute of Molecular Medicine at the Feinstein Institutes. “He changed our whole concept about how cells respond to hormones.”
Legacy of Innovation
Dr. Roth’s work wasn’t just about identifying the problem; it paved the way for targeted therapies designed to improve insulin sensitivity. Understanding how cells interact with hormones is now fundamental to treating not only diabetes, but also a range of metabolic disorders.
His contribution wasn’t just about clarifying the science of diabetes; it redefined how we approach hormonal diseases, impacting millions worldwide.
Dr. Roth’s passing marks the end of an era in endocrinology, but his legacy continues to drive research and inspire new generations of scientists. His work remains essential for improving the lives of those affected by diabetes and other hormone-related conditions.
